[BostonCard]

Here's the New England Journal article:

https://www.nejm.org/doi/full/10.1056/NE...2?query=RP

In the overall trial population, 6% of the patients in the placebo group and 3% of the patients in the combined REGN-COV2 dose groups reported at least one medically attended visit; among patients who were serum antibody–negative at baseline, the corresponding percentages were 15% and 6% (difference, −9 percentage points; 95% CI, −29 to 11).

The paper only reports "medically attended visit" as an endpoint, and I would guess that hospitalization is a small subset of that.  With a 3% absolute risk difference, you would have to treat 30 patients to prevent one "medically attended visit".

BC

[BostonCard]

Here's the New England Journal article:

https://www.nejm.org/doi/full/10.1056/NE...2?query=RP

In the overall trial population, 6% of the patients in the placebo group and 3% of the patients in the combined REGN-COV2 dose groups reported at least one medically attended visit; among patients who were serum antibody–negative at baseline, the corresponding percentages were 15% and 6% (difference, −9 percentage points; 95% CI, −29 to 11).

The paper only reports "medically attended visit" as an endpoint, and I would guess that hospitalization is a small subset of that.  With a 3% absolute risk difference, you would have to treat 30 patients to prevent one "medically attended visit".

BC